Home/Filings/8-K/0001493152-26-000418
8-K//Current report

BIOXYTRAN, INC 8-K

Accession 0001493152-26-000418

$BIXTCIK 0001445815operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:01 PM ET

Size

228.5 KB

Accession

0001493152-26-000418

Research Summary

AI-generated summary of this filing

Updated

Bioxytran, Inc. Officer Terminated; Ex-Officer Disputes Dismissal

What Happened
Bioxytran, Inc. (BIXT) filed an 8-K (Item 5.02) disclosing that, effective December 29, 2025, Mike Sheikh was terminated as an officer of the company. In a letter dated December 31, 2025, Mr. Sheikh is contesting the reason for his dismissal — a factor that could affect whether he is eligible for any severance benefits.

Key Details

  • Termination effective date: December 29, 2025.
  • Contest letter date from Mike Sheikh: December 31, 2025.
  • Dispute concerns the stated reason for dismissal, which the filing says is relevant to determining severance benefits, if any.
  • The filing included an interactive cover page exhibit (Inline XBRL).

Why It Matters
An officer’s termination and a subsequent dispute over the reason for dismissal can affect short-term management stability and may lead to potential severance costs or further disclosure if the matter is resolved or litigated. Investors should note the company disclosed the event under Item 5.02 and watch for any future filings or statements that provide outcomes, financial impacts, or replacements for the officer.